Research ArticleOriginal Article
Open Access

Prevalence of depression and anxiety among adult patients with multiple sclerosis at Riyadh City, Saudi Arabia

Norah A. Alharbi, Sadaga H. Alawi, Yousef M. Alharbi, Muath Y. Alharbi, Tareq N. Alsamarh, Adi A. Aldubaiyan, Saleh A. Alwasil and Abdulrahman A. Alomairi
Neurosciences Journal April 2022, 27 (2) 71-78; DOI: https://doi.org/10.17712/nsj.2022.2.20210101

References

  1. 1.↵
    1. Boeschoten RE,
    2. Braamse AM,
    3. Beekman AT,
    4. Cuijpers P,
    5. van Oppen P,
    6. Dekker J, et al.
    Prevalence of depression and anxiety in multiple sclerosis: a systematic review and meta-analysis. J Neurol Sci 2017; 372: 331–341.
    OpenUrlCrossRefPubMed
  2. 2.↵
    1. Brønnum-Hansen H,
    2. Koch-Henriksen N,
    3. Stenager E.
    Trends in survival and cause of death in Danish patients with multiple sclerosis. Brain 2004; 127: 844–850.
    OpenUrlCrossRefPubMedWeb of Science
  3. 3.↵
    1. Siegert RJ,
    2. Abernethy DA.
    Depression in multiple sclerosis: a review. J Neurol Neurosurg Psychiatr 2005; 76: 469–475.
    OpenUrlAbstract/FREE Full Text
  4. 4.↵
    1. Beiske AG,
    2. Svensson E,
    3. Sandanger I,
    4. Czujko B,
    5. Pedersen ED,
    6. Aarseth JH, et al.
    Depression and anxiety amongst multiple sclerosis patients. Eur J Neurol 2008; 15: 239–245.
    OpenUrlCrossRefPubMedWeb of Science
  5. 5.↵
    1. Benedict RH,
    2. Fishman I,
    3. McClellan MM,
    4. Bakshi R,
    5. Weinstock-Guttman B.
    Validity of the beck depression inventory-fast screen in multiple sclerosis. Mult Scler J 2003; 9: 393–396.
    OpenUrl
  6. 6.↵
    1. Honarmand K,
    2. Feinstein A.
    Validation of the Hospital Anxiety and Depression Scale for use with multiple sclerosis patients. Mult Scler J 2009; 15: 1518–1524.
    OpenUrl
  7. 7.↵
    1. Fruewald S,
    2. Loeffler-Stastka H,
    3. Eher R,
    4. Saletu B,
    5. Baumhacki U.
    Depression and quality of life in multiple sclerosis. Acta Neurol Scand 2001; 104: 257–261.
    OpenUrlCrossRefPubMedWeb of Science
  8. 8.
    1. Mohr DC,
    2. Goodkin DE,
    3. Likosky W,
    4. Gatto N,
    5. Baumann KA,
    6. Rudick RA.
    Treatment of depression improves adherence to interferon beta-1b therapy for multiple sclerosis. Arch Neurol 1997; 54: 531–533.
    OpenUrlCrossRefPubMedWeb of Science
  9. 9.↵
    1. Katon WJ.
    Epidemiology and treatment of depression in patients with chronic medical illness. Dialogues Clin Neurosci 2011; 13: 7–23.
    OpenUrlPubMed
  10. 10.↵
    1. Feinstein A.
    Multiple sclerosis, depression, and suicide. BMJ 1997; 315: 691–692.
    OpenUrlFREE Full Text
  11. 11.↵
    1. Feinstein A.
    An examination of suicidal intent in patients with multiple sclerosis. Neurology 2002; 59: 674–678.
    OpenUrlCrossRefPubMed
  12. 12.
    1. Sadovnick AD,
    2. Eisen K,
    3. Ebers GC,
    4. Paty DW.
    Cause of death in patients attending multiple sclerosis clinics. Neurology 1991; 41: 1193.
    OpenUrlCrossRefPubMed
  13. 13.↵
    1. Skokou M,
    2. Soubasi E,
    3. Gourzis P.
    Depression in multiple sclerosis: a review of assessment and treatment approaches in adult and pediatric populations. Int Sch Res Notices 2012; 2012.
  14. 14.↵
    The National Institute of Mental Health. Depression [Internet]. February. 2018. Available from: https://www.nimh.nih.gov/health/topics/depression/index.shtml
  15. 15.↵
    1. Lim GY,
    2. Tam WW,
    3. Lu Y,
    4. Ho CS,
    5. Zhang MW,
    6. Ho RC.
    Prevalence of depression in the community from 30 countries between 1994 and 2014. Sci Rep 2018; 8: 1-0.
  16. 16.↵
    Goldman Consensus Group. The Goldman Consensus statement on depression in multiple sclerosis. Mult Scler J 2005; 11: 328–337.
    OpenUrl
  17. 17.↵
    1. Minden SL,
    2. Feinstein A,
    3. Kalb RC,
    4. Miller D,
    5. Mohr DC,
    6. Patten SB,
    7. Bever C,
    8. Schiffer RB,
    9. Gronseth GS,
    10. Narayanaswami P.
    Evidence-based guideline: assessment and management of psychiatric disorders in individuals with MS: report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology 2014; 82: 174–181.
    OpenUrlCrossRefPubMed
  18. 18.↵
    1. Zigmond AS,
    2. Snaith RP.
    The hospital anxiety and depression scale. Acta Psychiatr Scand 1983; 67: 361–370.
    OpenUrlCrossRefPubMedWeb of Science
  19. 19.↵
    1. Terkawi AS,
    2. Tsang S,
    3. AlKahtani GJ,
    4. Al-Mousa SH,
    5. Al Musaed S,
    6. AlZoraigi US, et al.
    Development and validation of Arabic version of the Hospital Anxiety and Depression Scale. Saudi J Anaesth 2017; 11: S11.
    OpenUrlCrossRef
  20. 20.↵
    1. Vasilopoulou C,
    2. Bourtsi E,
    3. Giaple S,
    4. Koutelekos I,
    5. Theofilou P,
    6. Polikandrioti M.
    The impact of anxiety and depression on the quality of life of hemodialysis patients. Glob J Health Sci 2016; 8: 45–55.
    OpenUrl
  21. 21.↵
    1. Rishi P,
    2. Rishi E,
    3. Maitray A,
    4. Agarwal A,
    5. Nair S,
    6. Gopalakrishnan S.
    Hospital anxiety and depression scale assessment of 100 patients before and after using low vision care: A prospective study in a tertiary eye-care setting. Indian J Ophthalmol 2017; 65: 1203.
    OpenUrl
  22. 22.↵
    1. Kurtzke JF.
    Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983; 33: 1444–1452.
    OpenUrlCrossRefPubMed
  23. 23.↵
    1. Tauil CB,
    2. Grippe TC,
    3. Dias RM,
    4. Dias-Carneiro RP,
    5. Carneiro NM,
    6. Aguilar AC,
    7. Silva FM,
    8. Bezerra F,
    9. Almeida LK,
    10. Massarente VL,
    11. Giovannelli ED.
    Suicidal ideation, anxiety, and depression in patients with multiple sclerosis. Arquivos de neuro-psiquiatria 2018; 76: 296–301.
    OpenUrl
  24. 24.↵
    1. Karimi S,
    2. Andayeshgar B,
    3. Khatony A.
    Prevalence of anxiety, depression, and stress in patients with multiple sclerosis in Kermanshah-Iran: a cross-sectional study. BMC psychiatry 2020; 20: 1–8.
    OpenUrlCrossRef
  25. 25.↵
    1. Bahathig A,
    2. Alblowi MA,
    3. Alhilali AA,
    4. AlJasim BS,
    5. Alhelow M,
    6. Aldakheel H, et al.
    The Prevalence and Association of Depression and Anxiety With Multiple Sclerosis in Riyadh, Saudi Arabia: A Cross-Sectional Study. Cureus 2020; 12: e12389.
    OpenUrl
  26. 26.↵
    1. Alhussain H,
    2. Aldayel AA,
    3. Alenazi A,
    4. Alowain F.
    Multiple sclerosis patients in Saudi Arabia: prevalence of depression and its extent of severity. Cureus 2020; 12: e7005.
    OpenUrl
  27. 27.↵
    1. Alamri HS,
    2. Algarni A,
    3. Shehata SF,
    4. Al Bshabshe A,
    5. Alshehri NN,
    6. ALAsiri AM, et al.
    Prevalence of depression, anxiety, and stress among the general population in Saudi Arabia during Covid-19 pandemic. Int J Environ Res Public Health 2020; 17: 9183.
    OpenUrl
  28. 28.↵
    1. Alsaadi T,
    2. El Hammasi K,
    3. Shahrour TM,
    4. Shakra M,
    5. Turkawi L,
    6. Almaskari B, et al.
    Prevalence of depression and anxiety among patients with epilepsy attending the epilepsy clinic at Sheikh Khalifa Medical City, UAE: A cross-sectional study. Epilepsy Behav 2015; 52: 194–199.
    OpenUrlPubMed
  29. 29.↵
    1. Bener A,
    2. Abou-Saleh MT,
    3. Dafeeah EE,
    4. Bhugra D.
    The prevalence and burden of psychiatric disorders in primary health care visits in Qatar: Too little time?. J Family Med Prim Care 2015; 4: 89.
    OpenUrl
  30. 30.
    1. Alkhadhari S,
    2. Alsabbrri AO,
    3. Mohammad IH,
    4. Atwan AA,
    5. Alqudaihi F,
    6. Zahid MA.
    Prevalence of psychiatric morbidity in the primary health clinic attendees in Kuwait. J Affect Disord 2016; 195: 15–20.
    OpenUrlPubMed
  31. 31.↵
    1. Kadri N,
    2. Agoub M,
    3. El Gnaoui S,
    4. Berrada S,
    5. Moussaoui D.
    Prevalence of anxiety disorders: a population-based epidemiological study in metropolitan area of Casablanca, Morocco. Ann Gen Psychiatry 2007; 6: 1–6.
    OpenUrlCrossRefPubMed
  32. 32.↵
    1. Ahmadvand A,
    2. Sepehrmanesh Z,
    3. Sadat-Ghoreishi F,
    4. Afshinmajd S.
    Prevalence of psychiatric disorders in the general population of Kashan, Iran. Arch Iran Med 2012; 15: 205–209.
    OpenUrlPubMed
  33. 33.↵
    1. da Cruz Fernandes IM,
    2. Ribeiro AM,
    3. Gomes RL,
    4. Lopes JS,
    5. Vanderlei LC,
    6. Lorençoni RM.
    Anxiety, depression and stress among employees of a public higher education institution in São Paulo, Brazil. Rev Bras Med Trab 2019; 17: 530.
    OpenUrl
  34. 34.↵
    1. Pham T,
    2. Jetté N,
    3. Bulloch AG,
    4. Burton JM,
    5. Wiebe S,
    6. Patten SB.
    The prevalence of anxiety and associated factors in persons with multiple sclerosis. Mult Scler Relat Disord 2018; 19: 35–39.
    OpenUrl
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools
Bookmark this article

Jump to section